Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Nymox to report results of new phase II study of NX-1207 in BPH

Jan. 21, 2008

Shire launches Fosrenol in Spain, completing launch roll-out in E.U. markets

Jan. 18, 2008

Vasopressin V2 receptor agonists prepared and tested at Kissei

Jan. 17, 2008

Lung and renal improvement with sirolimus in tuberous sclerosis complex and LAM / News in Context

Jan. 14, 2008

Phase III study of oxybutynin topical gel for OAB meets primary and secondary endpoints

Jan. 10, 2008

Protox reports positive final results from phase I study of PRX-302 for BPH

Jan. 7, 2008

Novel 5-HT2C receptor agonists emerge from Takeda R&D

Dec. 24, 2007

Recent Sumitomo Chemical patents disclose novel therapeutic agents for chronic renal failure

Dec. 21, 2007

ZymoGenetics and Merck Serono initiate phase II/III clinical trial of atacicept

Dec. 17, 2007

BioMarin enters research and option agreement with IGAN for IgA proteases

Dec. 7, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal
BioWorld
Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...